Publicaciones (21) Publicaciones en las que ha participado algún/a investigador/a

1995

  1. Efficacy and safety of α-interferon treatment for chronic hepatitis C in HIV-infected patients

    Journal of Infection, Vol. 31, Núm. 1, pp. 9-13

  2. Epidemiology of HTLV-I/II infection in Spain

    Alpe Adria Microbiology Journal, Vol. 4, Núm. 2, pp. 85-94

  3. HTLV-I infection in Spain. Analysis of 24 cases identified until November, 1994. Spanish Group for the Study of HTLV-I/II)

    Medicina clínica, Vol. 105, Núm. 7, pp. 246-250

  4. High rate of co-infection with different hepatitis C virus subtypes in HIV-infected intravenous drug addicts in Spain

    Journal of Hepatology, Vol. 22, Núm. 5, pp. 598-599

  5. Human lymphotropic virus type I (HTLV-I)

    Medicina clínica, Vol. 104, Núm. 11, pp. 426-435

  6. Ion-pair reversed-phase and low-molecular-weight aqueous gel permeation high-performance liquid chromatography methods for the determination of amoxicillin oligomers

    Chromatographia, Vol. 41, Núm. 5-6, pp. 651-656

  7. Ion-pair reversed-phase and low-molecular-weight aqueous gel permeation high-performance liquid chromatography methods for the determination of amoxicillin oligomersa

    Chromatographia, Vol. 41, Núm. 11-12, pp. 651-656

  8. La negociación del convenio-ley español de capellanías de 1867

    Ius canonicum, Vol. 35, Núm. 70, pp. 605-671

  9. Morbidity and mortality associated with chronic viral hepatopathy in patients infected with the human immunodeficiency virus

    Medicina clínica, Vol. 104, Núm. 17, pp. 641-644

  10. PROGRESION RAPIDA A SIDA EN UN PACIENTE INFECTADO CON UNA CEPA DEL VIH-1 FORMADORA DE SINCITIOS

    Medicina Clinica, Vol. 105, Núm. 3, pp. 99-100

  11. Phylogenetic relationship and geographic distribution of multiple human T- cell lymphotropic virus type II subtypes

    Journal of Virology, Vol. 69, Núm. 2, pp. 621-632

  12. Prevalence of human T-cell lymphotropic virus type 1 (HTLV-1) and HTLV-2 infection among Spanish drug users measured by HTLV-1 assay and HTLV-1 and - 2 assay

    Journal of Clinical Microbiology, Vol. 33, Núm. 7, pp. 1735-1738

  13. Prevalence of infection by human T-cell leukemia virus types I and II in southern Spain

    European Journal of Clinical Microbiology & Infectious Diseases, Vol. 14, Núm. 8, pp. 686-690

  14. Residual risk of retrovirus transmission by transfusions

    Revista clínica española, Vol. 195, Núm. 6, pp. 418-424

  15. Sequence Analysis of the V1/V2 and V3 Domains in an HIV-Seronegative AIDS Patient

    AIDS Research and Human Retroviruses, Vol. 11, Núm. 12, pp. 1539-1541

  16. Strategies for the prevention of human immunodeficiency virus infection

    Revista clínica española, Vol. 195, Núm. 10, pp. 701-707

  17. The actual risk of retrovirus transmission from transfusions

    Sangre, Vol. 40, Núm. 5, pp. 407-416

  18. The quantification of human immunodeficiency virus viremia in patients with rapid and slow progression of the disease

    Medicina clínica, Vol. 104, Núm. 14, pp. 530-534

  19. The rapid and slow progression of HIV infection

    Revista clínica española, Vol. 195, Núm. 10, pp. 708-714

  20. Type 2 human immunodeficiency virus infection (HIV-2) in Spain: analysis of the first 50 cases. Spanish Group for the Study of HIV-2

    Medicina clínica, Vol. 105, Núm. 7, pp. 241-245